CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care, oncology and specialty pharmacists, will host the third of its 2019 Directions in Oncology Pharmacy™ fall conference series on Saturday, Oct. 19, at the Wyndham Grand Orlando Resort Bonnet Creek Hotel, in Orlando, Florida.
This one-day pharmacy conference will provide live practical education to pharmacists in the inpatient, ambulatory, infusion and specialty pharmacy practice settings. During this conference session, attendees will be able to examine recently approved and expanded indications for immunotherapy and targeted therapies, analyze the current guidelines for solid and hematologic malignancies and identify the role of pharmacists in a variety of circumstances, such as managing adverse effects, educating the health care teams and patients, improving patient adherence and coordinating care to improve patient outcomes.
The Directions in Oncology Pharmacy™ fall conference series is held in major cities across the United States and offers pharmacists opportunities to participate in an accredited keynote address as well as eight interactive sessions. The keynote presentation on oncology value-based care will be given by Emily Mackler, Pharm.D., BCOP, director of Clinical Quality Initiatives at the Michigan Oncology Quality Consortium. These meetings focus on evolving treatment strategies, including the use of checkpoint inhibitors and targeted oral and infusion therapies for the care of patients with solid tumors and hematologic malignancies. Sessions include head and neck cancer, melanoma, chronic lymphocytic leukemia, non-Hodgkin lymphoma, hepatocellular carcinoma, oncology biosimilars, triple-negative breast cancer and acute myeloid leukemia. They will highlight evidence for new therapies and pharmacists’ roles in delivering care to optimize patient outcomes. Accredited by the Accreditation Council for Pharmacy Education, each meeting provides attendees with the opportunity to earn up to 6.75 continuing education credits, including law and patient safety credit.
This conference is supported by educational grants from Agios Pharmaceuticals Inc.; Celgene Corporation; Eisai; Jazz Pharmaceuticals; Merck Sharp & Dohme Corp.; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech Inc.
For more information and to register for the conference, click here.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team. PTCE is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.